2m 2m 2m 2m 2m 2m 2m
LARIMAR THERAP (LRMR)
NASDAQ
$4.18+$0.001 (+0.02%)
Price as of Aug 21, 2026 7:58 PM EDT- $434.2MMarket Cap
- 6.91%1-Year Change
- BiotechnologyIndustry
LARIMAR THERAP (LRMR)
$4.18+$0.001 (+0.02%)
LRMR | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $4.18 | ||
Change | +$0.02 (+0.48%) | ||
Open | $4.20 | ||
High | $4.21 | ||
Low | $4.08 | ||
Previous Close | $4.16 | ||
Volume | 699,420 | ||
30-Day Average Volume | 1,198,287 | ||
1-Week Change | -4.13% | ||
1-Month Change | 6.36% | ||
1-Year Change | 6.91% | ||
3-Year Change | 5.82% | ||
5-Year Change | -69.84% | ||
Fundamentals | |||
Shares Outstanding | 103.9M | ||
Total Assets | $165.3M | ||
Market Cap | $434.2M | ||
Enterprise Value | $341.5M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$32.8M | ||
Free Cash Flow | -$44.1M | ||
EBIT | -$32.8M | ||
EBITDA | -$32.7M | ||
Net Working Capital | $126.5M | ||
EPS | $0.30 | ||
Enterprise Value/EBITDA | -10 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 3 | ||
P/E | 14 | ||
PEG | 0 | ||
Price/Free Cash Flow | -10 | ||
Price/Operating Cash Flow | -10 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue